SHILPAMED.NSSHILPAMED.NSNSE
Loading
R&D Expense Growth AcceleratingAccelerating
Percentile Rank57
3Y CAGR-3.6%
5Y CAGR-5.1%
Year-over-Year Change
Year-over-year research & development expense growth
3Y CAGR
-3.6%/yr
vs +47.5%/yr prior
5Y CAGR
-5.1%/yr
Consistent
Acceleration
-51.1pp
Decelerating
Percentile
P57
Within normal range
vs 5Y Ago
0.8x
Contraction
Streak
1 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | 56.27% |
| 2024 | -36.96% |
| 2023 | -10.82% |
| 2022 | 62.86% |
| 2021 | -8.37% |
| 2020 | 73.21% |
| 2019 | -21.90% |
| 2018 | 13.29% |
| 2017 | -21.26% |
| 2016 | 92.30% |